Lombard Odier Asset Management (Europe)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,272
| Closed | -$1.78M | – | 267 |
|
|
2024
Q1 | $1.78M | Sell |
26,272
-36
| -0.1% | -$2.44K | 0.11% | 162 |
|
|
2023
Q4 | $1.77M | Buy |
26,308
+81
| +0.3% | +$5.46K | 0.1% | 162 |
|
|
2023
Q3 | $1.78M | Sell |
26,227
-65
| -0.2% | -$4.4K | 0.09% | 186 |
|
|
2023
Q2 | $1.88M | Sell |
26,292
-1,067
| -4% | -$76.4K | 0.09% | 190 |
|
|
2023
Q1 | $1.9M | Sell |
27,359
-2,489
| -8% | -$173K | 0.09% | 192 |
|
|
2022
Q4 | $2.02M | Sell |
29,848
-1,219
| -4% | -$82.6K | 0.08% | 197 |
|
|
2022
Q3 | $1.7M | Sell |
31,067
-3,463
| -10% | -$190K | 0.09% | 182 |
|
|
2022
Q2 | $2.28M | Buy |
+34,530
| New | +$2.28M | 0.11% | 167 |
|